FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 357:154-162 July 12, 2007 Number 2 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text  Full Text Audio PowerPoint Slide Set Supplementary Material Purchase this article Editorial by Hartge, P. Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the authors' clinical recommendations.

A healthy 33-year-old woman comes to establish care. She reports no breast symptoms, her age at menarche was 14, and she has no children. She notes a family history of early-onset breast cancer in her sister (whose condition was diagnosed at the age of 35 years and who is alive at 39 years), mother (diagnosed at 37 years and alive at 60 . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Risk Assessment and Genetic Testing

Specialized Breast-Cancer Surveillance

            Breast Examination

            Mammography

            Magnetic Resonance Imaging

            Ultrasonography

Screening for Other Cancers

Strategies for Reducing Risks

            Chemoprevention

            Surgery

Areas of Uncertainty

Recommendations from Professional Societies

Summary and Conclusions

Source Information

From the Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York.

Address reprint requests to Dr. Robson at the Clinical Genetics Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021, or at robsonm@mskcc.org.

Related Letters:

Management of an Inherited Predisposition to Breast Cancer
Sardanelli F., Podo F., Robson M., Offit K.
Extract | Full Text | PDF  
N Engl J Med 2007; 357:1663, Oct 18, 2007. Correspondence

This article has been cited by other articles:

• Kriege, M., Seynaeve, C., Meijers-Heijboer, H., Collee, J. M., Menke-Pluymers, M. B.E., Bartels, C. C.M., Tilanus-Linthorst, M. M.A., Blom, J., Huijskens, E., Jager, A., van den Ouweland, A., van Geel, B., Hooning, M. J., Brekelmans, C. T.M., Klijn, J. G.M. (2009). Sensitivity to First-Line Chemotherapy for Metastatic Breast Cancer in BRCA1 and BRCA2 Mutation Carriers. JCO 27: 3764-3771 [Abstract] [Full Text]  
• Offit, K. (2009). Breast Cancer Single-Nucleotide Polymorphisms: Statistical Significance and Clinical Utility. JNCI J Natl Cancer Inst 101: 973-975 [Full Text]  
• Evans, D. G. R., Lennard, F., Pointon, L. J., Ramus, S. J., Gayther, S. A., Sodha, N., Kwan-Lim, G. E., Leach, M. O., Warren, R., Thompson, D., Easton, D. F., Eeles, R., on behalf of The UK study of MRI screening for bre, (2009). Eligibility for Magnetic Resonance Imaging Screening in the United Kingdom: Effect of Strict Selection Criteria and Anonymous DNA Testing on Breast Cancer Incidence in the MARIBS Study. Cancer Epidemiol. Biomarkers Prev. 18: 2123-2131 [Abstract] [Full Text]  
• Pensabene, M., Spagnoletti, I., Capuano, I., Condello, C., Pepe, S., Contegiacomo, A., Lombardi, G., Bevilacqua, G., Caligo, M. A. (2009). Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol 20: 874-878 [Abstract] [Full Text]  
• Zhang, L., Kirchhoff, T., Yee, C. J., Offit, K. (2009). A Rapid and Reliable Test for BRCA1 and BRCA2 Founder Mutation Analysis in Paraffin Tissue Using Pyrosequencing. J. Mol. Diagn. 11: 176-181 [Abstract] [Full Text]  
• Fortuny, D., Balmana, J., Grana, B., Torres, A., Cajal, T. R. y, Darder, E., Gadea, N., Velasco, A., Lopez, C., Sanz, J., Alonso, C., Brunet, J. (2009). Opinion about reproductive decision making among individuals undergoing BRCA1/2 genetic testing in a multicentre Spanish cohort. Hum Reprod 24: 1000-1006 [Abstract] [Full Text]  
• Huo, D., Senie, R. T., Daly, M., Buys, S. S., Cummings, S., Ogutha, J., Hope, K., Olopade, O. I. (2009). Prediction of BRCA Mutations Using the BRCAPRO Model in Clinic-Based African American, Hispanic, and Other Minority Families in the United States. JCO 27: 1184-1190 [Abstract] [Full Text]  
• Shaham, D., Libson, E., Graif, M. (2008). Radiology in Israel: What Is Happening?. Am. J. Roentgenol. 191: 951-953 [Full Text]  
• Turner, N. C, Jones, A. L (2008). Management of breast cancer--Part I. BMJ 337: a421-a421 [Full Text]  
• Rebora, P., Czene, K., Reilly, M. (2008). Timing of Familial Breast Cancer in Sisters. JNCI J Natl Cancer Inst 100: 721-727 [Abstract] [Full Text]  
• Briasoulis, E., Roukos, D. H. (2008). Contralateral Prophylactic Mastectomy: Mind the Genetics. JCO 26: 1909-1910 [Full Text]  
• Offit, K. (2008). Genomic Profiles for Disease Risk: Predictive or Premature?. JAMA 299: 1353-1355 [Full Text]  
• Sardanelli, F., Podo, F., Robson, M., Offit, K. (2007). Management of an Inherited Predisposition to Breast Cancer. NEJM 357: 1663-1663 [Full Text]